US20010044649A1 - Stents for angioplasty - Google Patents
Stents for angioplasty Download PDFInfo
- Publication number
- US20010044649A1 US20010044649A1 US09/410,303 US41030399A US2001044649A1 US 20010044649 A1 US20010044649 A1 US 20010044649A1 US 41030399 A US41030399 A US 41030399A US 2001044649 A1 US2001044649 A1 US 2001044649A1
- Authority
- US
- United States
- Prior art keywords
- segment
- stent
- annular
- segments
- bridge elements
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002399 angioplasty Methods 0.000 title description 2
- 230000006835 compression Effects 0.000 claims abstract description 11
- 238000007906 compression Methods 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 208000031481 Pathologic Constriction Diseases 0.000 claims description 4
- 208000037803 restenosis Diseases 0.000 claims description 4
- 208000037804 stenosis Diseases 0.000 claims description 3
- 230000036262 stenosis Effects 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 description 25
- 239000000463 material Substances 0.000 description 11
- 230000008901 benefit Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 3
- 210000003850 cellular structure Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 229910001000 nickel titanium Inorganic materials 0.000 description 3
- 210000005166 vasculature Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 229910000619 316 stainless steel Inorganic materials 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000005219 brazing Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000007514 turning Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91583—Adjacent bands being connected to each other by a bridge, whereby at least one of its ends is connected along the length of a strut between two consecutive apices within a band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0036—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
Definitions
- the present invention relates to stents for angioplasty.
- the invention relates to a stent having a cellular design.
- stent is intended to indicate devices useful for endoluminal insertion (for example, in a blood vessel), usually effected by means of catheterization, with subsequent deployment in place so as to achieve local support of the lumen.
- the primary purpose of the stent is to eliminate and avoid the restenosis (i.e., narrowing or closure) of the treated area.
- the stent while moving toward the treatment site, the stent should be capable of adapting to the path, which may include various curved sections;
- distortion of the stent while it is being positioned should not be detrimental to the ability of the stent to provide an effective support when it is positioned and deployed;
- an extensive support surface should be provided to the wall of the lumen which is being supported
- the stents should be able to be simply and reliably produced using available technology and they should incorporate the requirements listed above.
- a stent is subject to various forces, including compression, flexure, and torsion. These stresses often cause the stent to perform in an undesirable manner. Additionally, a significant disadvantage of current stent designs is their failure to distribute these stresses throughout the structure of the stent. Each of these stresses is maximized in a particular area of the stent. In current stent designs two or more of these areas of maximum stress overlap. This results in at least two problems. First, an overlap of the maximum stress areas may overly fatigue the stent and cause failure in an area of overlapped maximum stress. Second, the failure to distribute or discharge the maximum stress of these forces at different areas causes stress concentration on the vessel wall which may cause vessel wall injury. Thus what is needed in the art is a stent meeting the requirements listed above that will avoid stress concentration and elastic distortion as well as provide good elastic matching between the stent and the vessel into which it is placed.
- This invention is a stent having a substantially tubular body defining a longitudinal axis comprising first and second adjacent annular segments, each segment defining a substantially sinusoidal shape having a plurality of peaks and valleys, the peaks of the first segment extending toward the second segment and being aligned longitudinally with the valleys of the second segment; a plurality of bridge elements having a U-shaped portion between first and second connector arms, the first connector arm of one bridge element being connected between a first peak and a first valley of the first segment and the second connector arm being connected between a first peak and a first valley of the second segment in a manner such that the U-shaped portion extends in the direction of the first peak of the first segment and the first valley of the second segment.
- the U-shaped portion of the plurality of bridge elements may be oriented in the same direction. Alternately, they may be oriented in one direction between one pair of adjacent annular segments, and in the opposite direction between another pair of adjacent annular segments.
- the connector arm of the bridge element joins the annular segment at the zero point of the sinusoidal wave shape.
- each connector arm joins each annular segment at zero points of the sinusoidal wave separated by 360°. Alternately, the connector arms may join zero points separated by 360° between one pair of adjacent segments, and zero points separated by 720° between another pair of adjacent segments.
- this invention is a method of preventing restenosis by providing the stent described above and deploying it within a body lumen.
- this invention is a method of making a stent by providing a tubular blank and forming the tubular blank into a stent having the geometry described above.
- this invention is a stent having a substantially tubular body defining a longitudinal axis.
- the stent comprises first and second adjacent annular segments, each segment having a substantially sinusoidal wave shape.
- the stent further includes first and second bridge elements, the first bridge element having a first end connected to the first annular segment at a zero point of the sinusoidal wave shape and having a second end connected to the second annular segment at a zero point of the sinusoidal wave shape.
- the second bridge element has a first end connected to the first annular segment at a zero point of the sinusoidal wave shape spaced 360° from the connection of the first bridge element to the first annular segment and a second end connected to the second annular segment at a zero point of the sinusoidal wave shape 360° from the connection of the first bridge element to the second segment, the first and second bridge elements and a portion of the first and second annular segments between the connection points of the bridge elements together defining a cell.
- the invention is a stent having a substantially tubular body defining a longitudinal axis and having a plurality of annular segments, each segment having a substantially sinusoidal wave shape.
- the stent includes a plurality of bridge elements, each bridge element having a first end connected to one annular segment at a zero point of the sinusoidal wave shape and a second end connected to an annular segment adjacent to the one annular segment at a zero point of the sinusoidal wave shape of the adjacent annular segment, the annular segments and bridge elements being configured such that when compression, flexure and torsion forces are applied to the stent they generate first maximum stress regions, second maximum stress regions, and third maximum stress regions, where the first, second and third maximum stress regions do not overlap.
- FIG. 1 is a plan view of the tubular stent of the present invention cut longitudinally and opened to lie within a single plane, the stent being in a radially contracted configuration.
- FIG. 2 illustrates the stent of FIG. 1 in its radially expanded configuration.
- FIG. 3( a ) illustrates an expanded view of a single cell within the wall of the stent of FIG. 2 and FIGS. 3 ( b ), 3 ( c ), 3 ( d ), 3 ( c ) and 3 ( f ) show the cross-sectional areas of portions of the stent.
- FIGS. 4 ( a ) to 4 ( f ) illustrate the effects of compression, flexure, and torsion, respectively, on a cell of the stent of this invention.
- FIGS. 5 ( a ) to 5 ( f ) illustrate various shapes of the wall of a continuous tubular blank used to make the stent of this invention.
- FIGS. 6 ( a ) and 6 ( b ) illustrate the variation in cross section of a section of the stent of this invention.
- FIG. 7 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
- FIG. 8 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
- FIG. 9 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
- FIG. 10 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
- a stent is inserted into a lumen, such as a blood vessel, at a site where stenosis, i.e., narrowing or stricture, is to be corrected.
- the stent is a tubular envelope, tubular body, or cylinder having apertured walls, such as, for example, a mesh-like structure.
- the stent typically has dimensions between several millimeters and several tens of millimeters in length, and a wall thickness of the order of, for example, several hundredths of millimeters.
- the stent is normally positioned in situ by catheterization through the vasculature followed by radial expansion from an introduction diameter of, for example, about 1.0 to 1.5 mm, to an expanded diameter of, for example, about 3 to 4 mm.
- the stent exerts a supporting force on the lumen, thereby avoiding or at least slowing restenosis of the vessel.
- the external diameter of the stent in the radially-contracted condition is chosen to enable the introduction of the stent into a lumen, while the expanded diameter corresponds to the diameter required to be maintained in the lumen once the stenosis has been eliminated. It should also be remembered that, although the principle application of the stent described is in relation to the treatment of blood vessels, it may also be useful as a support element for any lumen present in the human or animal body.
- the stent of this invention is a tubular body, i.e., a cylinder, with an open, or apertured, mesh-like structure.
- the stent is capable of being dilated from a radially-contracted position to a radially-expanded position.
- the tubular body is comprised of a wall having an inner surface and an outer surface defining a radial stent thickness therebetween.
- the material making up the mesh-like structure of the stent varies in its cross-sectional shape and/or cross-sectional area.
- this cross-sectional variation (and thus a variation in thickness and/or width in the stent wall) produces a particularly desirable stent because the strength, flexibility, and support of the stent may be varied in localized areas.
- the width as measured along the circumference of the tubular body and/or the radial thickness are made smaller to enhance flexibility.
- the width and/or thickness are made larger.
- the width is increased to provide added vascular support.
- the stent is shown in planar views so that the geometry of the stent may be seen easily.
- the body of the stent extends longitudinally in the direction identified as the Z axis. It also lies in the Z plane, i.e., a plane coincident with the Z axis.
- the stent may be flexed, bent or folded; thus good flexibility is one of the required characteristics of the stent.
- Another important characteristic of both the design and the material of the stent includes strength, i.e., the ability to withstand stresses due to compression, flexure, and torsion, as discussed further below.
- FIG. 1 illustrates a plan view of the stent of this invention.
- the body of stent 1 is comprised of a plurality of successive segments 2 of generally annular form.
- FIG. 1 shows a stent comprising eight annular segments 2 .
- the length of segments 2 measured in the longitudinal direction may range up to several millimeters (mm) but preferably is approximately 2 mm. That is, segments 2 are fairly “short” in comparison to the total length of the stent.
- bridge elements 8 which are actually integral components of the stent wall that connect adjacent segments 2 and enable stent 1 to flex or bend.
- Radiopaque marker 13 optionally is provided. Marker 13 is integral with segments 2 and typically is located on the proximal and/or distal ends of the stent. “Proximal and distal ends” refers to the portion of the stent nearest and farthest, respectively, from the point of entry of the stent into the vasculature. Suitable radiopaque markers include metals such as platinum, tantalum, gold, and alloys of these metals. Such markers permit exact placement of a stent within the vasculature of a patient. During manufacture the radiopaque marker may be crimped into a hole in the stent wall.
- the longitudinal flexibility of stent 1 necessary to assist in its delivery and location at the implantation site, is essentially due to bridge elements 8 , while its structural strength, that is, its support of the lumen, is due primarily to the structure of segments 2 .
- the desired characteristics of the stent can be obtained by adapting the arrangement and relationship of the bridge elements and the segments.
- FIG. 1 shows a plan view of a stent which has been cut open and laid flat; that is, the stent is no longer in a tubular shape.
- FIG. 1 illustrates that each segment 2 has a serpentine or sinusoidal wave shape.
- Each segment comprises peaks 4 and valleys 6 .
- Each annular segment is a mirror image of an adjacent annular segment about a plane perpendicular to the longitudinal axis of the stent. Thus, the peaks of one segment are aligned longitudinally with valleys of an adjacent segment.
- the term “sinusoidal wave shape” means that the annular segments have an undulating repeating pattern similar to that of a sine wave. It is not intended to mean that the shape is limited to that of a sine wave.
- Bridge elements 8 separate adjacent segments and maintain a distance between them in both the expanded and contracted conditions.
- Each bridge element 8 comprises a concave portion, or U-shape 10 , having apex 12 .
- the U-shape is adjoined to two connector arms 14 which extend from the U-shape and adjoin adjacent sinusoidal-shaped segments 2 at a zero point of the sinusoidal wave shape of each segment.
- the point of connection is between a peak and a valley of each segment such that the apex of the U-shape extends in the direction of the converging peak and valley that is nearest the attachment of the connector arm. These arms extend away from the U-shape and curve back to join the segments in the direction of the apex of the U-shape.
- these arms form an angle ⁇ of about 90 degrees with the U-shape.
- Bridge elements 8 are relatively flexible and change shape only slightly from the contracted to the expanded condition, as can be seen in FIGS. 1 and 2.
- Arms 14 adjoin adjacent sinusoidal wave shaped segments between a peak and a valley and preferably at zero-point 11 of the sinusoidal shape. (On a sine curve plotted on an X and Y axis, the “zero-point” is that point that intersects the X axis.)
- FIGS. 1 and 2 illustrate an embodiment of the stent of this invention wherein the connector arms of each bridge element adjoin alternate zero points of each adjacent segment. That is, in terms of the sinusoidal wave shape of each segment, bridge elements are connected at zero points separated by 360°. This results in even spacing of bridge elements between adjacent segments.
- the bridge elements are oriented in the same direction; that is, the U-shaped portion of each bridge element faces the same direction. It has been found that connection of the bridge elements at the zero points not only produces a very elastic joint but also results in the longitudinal length of the stent being the same in the contracted condition and the expanded condition and in all degrees of expansion therebetween.
- FIG. 1 A radially-contracted condition of the stent is illustrated in FIG. 1. This condition is slightly expanded from the stents fully contracted delivery condition so that the details of the stents structure may be more clearly shown.
- FIG. 2 shows that a segment 2 is elongated compared to the same segment in FIG. 1. That is, the segments retain the sinusoidal shape, but the amplitude and the frequency of the sine wave is less in the expanded condition than in the contracted condition.
- FIGS. 1 and 2 also show that the connector arms 14 remain substantially parallel to the longitudinal axis of the stent in both the radially contracted position (FIG. 1) and radially expanded position (FIG. 2).
- FIG. 3( a ) is a view of one cell of the stent of FIG. 2.
- FIGS. 1 and 2 illustrate that the stent is made up of individual, interconnected cells, each cell having the same size and shape.
- FIGS. 3 ( b ) to 3 ( f ) illustrate that the cross sectional shape and area of the material making up the stent varies over the cell.
- the perimeter of a cell is formed from portions of adjacent sinusoidal segments ( 2 a and 2 b ) and two bridge elements ( 8 a and 8 b ).
- Sinusoidal segment portions 2 a and 2 b are 360° portions of the sinusoidal wave shape of the annular segments.
- Arms 14 a and 14 a ′ extend from U-shape portion 10 a of bridge element 8 a .
- Apex 12 a of bridge 8 a is oriented in the same direction as apex 12 b of bridge 8 b .
- Bridges 8 a and 8 b adjoin adjacent segments 2 a and 2 b at zero points 11 of the sinusoidal shape; that is, between the peaks and valleys of the segments.
- Bridge element 8 b having U-shape 10 b , apex 12 b , and arms 14 b and 14 b ′, forms the remainder of the cell.
- FIGS. 3 ( b ), 3 ( c ), 3 ( d ), 3 ( e ) and 3 ( f ) show the shape and size of the cross-section of different portions of the cell taken along lines b-b, c-c, d-d, e-e and f-f respectively. It is preferred that the cross-sectional area of the material making up the stent vary. The cross-sectional shape may vary as well. An alternate way of describing this is that the width of the material making up the stent of FIGS.
- 1 and 2 may be different than the thickness of that portion (i.e., the dimension in a plane X, perpendicular to plane Z). It has been found that varying the cross-sectional area of different portions of the material of the stent produces optimum strength, flexibility, and support, enabling the stent to accommodate the differing stresses it encounters during use.
- FIGS. 4 ( a ) to 4 ( f ) illustrate the effects of compression, flexure, and torsion, respectively, on one cell of the stent of this invention.
- the arrows indicate the direction of the forces applied to the stent.
- the areas of the stent cell having the greatest stress concentration are indicated by solid lines.
- FIG. 4( a ) the stent is subjected to a compression force.
- FIG. 4( b ) shows that the areas of greatest stress occurs at the peaks and valleys of the sinusoidal shaped segments.
- FIG. 4( c ) shows s stent undergoing flexure.
- FIG. 4( d ) indicates that the areas of greatest stress occur at the apex of the U-shape of the bridge.
- FIG. 4( e ) shows a stent under torsion.
- FIG. 4( f ) indicates that the maximum stress occurs at the areas where the bridge joins the sinusoidal shaped segments, i.
- the stents of this invention it is possible to alter the thickness and width of various portions of the stent during the manufacturing process.
- One way to do this is to form the desired wall geometry in a continuous tubular blank and then cut or machine the stent from this blank.
- techniques such as laser incision, photo-incision, and electroerosion may be used to form a desired geometry. In this way, the stent bridges and sinusoidal segments are formed.
- FIG. 5 a shows a continuous tubular blank from which stents can be formed.
- the tubular blank has outer surface 51 forming the outer diameter and inner surface 53 forming the inner diameter; surfaces 51 and 53 are separated by wall thickness 55 .
- the characteristics of the stent including wall thickness and shape can be varied in accordance with the shape and surface configuration of inner and outer surfaces 53 and 51 of the tubular blank. Accordingly, the wall of the stent may be formed so that it has a variety of cross sectional shapes.
- FIGS. 5 ( b ) to 5 ( f ) show a section or slice of differently shaped tubular blanks between lines a-a′ and illustrate various wall shapes.
- the inner and outer surfaces of the tubular blank may be substantially parallel as in FIG. 5 b .
- FIGS. 5 ( e ) and 5 ( f ) illustrate tube walls having variable inside and outside diameters. Such tubular blanks are then machined to form the desired stent as described above. The result is that the desired thicknesses and widths can be provided to different portions of the stent.
- FIGS. 6 ( a ) and 6 ( b ) show a further embodiment of the invention and illustrate how the shape of the wall of a continuous tubular blank corresponds to the stent of this invention.
- FIG. 6( a ) shows a longitudinal cross-section of a portion of a tubular blank having a constant inner diameter but varying outer diameter. This blank is then used to form the sinusoidal segments and bridges of the stent.
- FIG. 6( b ) shows that the regions of the bridges adjoining the sinusoidal shaped segments (i.e., at the zero point) may be made with a smaller thickness than the remaining portions of the stent.
- This stent comprises bridge elements 78 adjoining sinusoidal shaped segments 72 at zero points 71 of the sinusoidal shape.
- the bridge elements are evenly spaced.
- the bridge elements are spaced apart 720° along the sinusoidal shape of the segments.
- the apices of each bridge element face the same direction.
- the stent of FIG. 4 illustrates cells all having the same shape and size. In contrast to FIGS. 1 and 2, this stent has fewer connecting bridges and fewer cells.
- the stent of FIG. 8 is a hybrid of FIGS. 1 and 6.
- Bridge elements 88 adjoin adjacent segments 82 at zero points 81 of the sinusoidal shape. All bridge elements are oriented similarly (i.e., face the same direction). The bridge elements adjoining adjacent segments are evenly spaced. However, the number and spacing of bridge elements is not the same for each pair of adjacent segments. This results in cells of unequal size and may produce regions of variable flexibility as well as strength.
- An advantage to having a greater number of bridge elements (and hence cells) at either end of the stent is that they provide additional stability and strength to the ends of the stent while having fewer cells in the middle portion of the stent provides additional flexibility.
- FIG. 9 Another variation of the stent is illustrated in FIG. 9.
- the bridge elements are evenly spaced throughout the stent, forming cells all of equal size and shape.
- apices for example, 90 a and 90 b
- bridge elements 98 face opposite directions in adjacent pairs of segments 92 .
- FIG. 10 illustrates yet another variation of the stent, wherein U-shaped portions 100 a and 100 b of bridge elements 108 a and 108 b , respectively, are facing in opposite directions in adjacent pairs of segments 102 and wherein the cells formed at each end of the stent are of different size than those of the remaining cells.
- the bridge elements adjoining any pair of adjacent segments are evenly spaced, but the number and spacing of bridge elements is not the same for each pair of adjacent segments. This results in cells of unequal size, and, in similar fashion to FIG. 8, produces regions of greater strength at either end of the stent.
- the bridge elements between adjacent sinusoidal segments with the apices pointing in the direction of a converging peak and valley of the adjacent segments.
- This configuration provides a number of advantages.
- One advantage is that, in the expanded configuration, the stent cell structure is sufficiently open to permit access to the lumen. For example, it is possible to manipulate catheters through the stent wall into vessel bifurcations in order to treat those vessels.
- Another advantage is that the stent geometry provides a smooth profile for delivery when in the contracted position.
- the U-shape of the connecting bridges lies between a converging valley and peak of adjacent sinusoidal segments and acts as a bridge therebetween.
- peaks or valleys of some prior art stents protrude especially when the stent is bent during delivery. This protruding peak or valley can snag on a vessel wall or plaque, making delivery and positioning of the stent difficult.
- a further advantage is provided by the configuration of the bridge elements.
- the connector arms and U-shaped portion of the bridge elements act in cooperation with the segments to provide an effective support surface for the vessel wall while at the same time minimizing the amount of stent material which must be used.
- the most widely used method is to use a balloon catheter, disposing the stent about the balloon of the catheter in the contracted condition and then expanding the balloon once the stent has been delivered to the deployment site.
- Different solutions are also possible, such as using superelastic materials that expand when the stent reaches the implantation site. Typically these materials are held in a contracted condition by means of a containment element that is released when the stent has reached the desired location and position.
- Materials having a “shape memory” that expand from a first configuration to a second expanded configuration when heated to a transition temperature (i.e., body temperature) also may be used in order to achieve the radial expansion in the implant position.
- the stent is made from a metal capable of satisfying two fundamental requirements: the ability to deform during the expansion phase and the ability to resist forces which could lead to contraction of the stent. That is, the stent retains the expanded shape.
- the stents of this invention may comprise 316 stainless steel or a shape memory material known under the commercial designation “Nitinol”. “Nitinol” is a nickel-titanium alloy that has been shown to be successful due to its superelasticity as well as its shape memory. Stents also may comprise biodegradable and/or biocompatible polymers, as known to one of skill in the art.
- the stent of this invention comprises a tubular body with an apertured wall.
- Methods of making the stent include:
- forming the stent from a continuous tubular blank intended to be segmented into individual stents, with the apertured parts being formed using techniques such as laser incision, photo-incision, electroerosion, and the like;
- the first arrangement described is the one currently preferred for producing stents of this invention.
- the use of laser beams to cut a continuous tubular blank has been shown to be the most flexible way to modify rapidly the characteristics of the stent during production.
- Such methods may be used to produce a stent having either constant or variable wall thickness, and, in either case, with wall material having different cross-sections. These methods include making the stent from a continuous tubular blank and machining, grinding, chemically etching, or electron discharge machining the tube to produce the desired pattern and also obtain sections of desired cross-section. Alternatively, a tubular blank having constant or variable thickness down its length could be laser cut to form the desired arrangement of segments and bridges. A stent could be formed and then the inside surface could be turned or micro-etched.
- the production method is not critical to the stents of this invention, as they may be formed by any desired method. This applies to the choice of the individual techniques and the order in which the various operations (the production of the apertured parts, segmentation, possible folding of the strip-like element, etc.) are performed.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Surgical Instruments (AREA)
- Laser Surgery Devices (AREA)
Abstract
Description
- The present invention relates to stents for angioplasty. In particular, the invention relates to a stent having a cellular design.
- The term “stent” is intended to indicate devices useful for endoluminal insertion (for example, in a blood vessel), usually effected by means of catheterization, with subsequent deployment in place so as to achieve local support of the lumen. The primary purpose of the stent is to eliminate and avoid the restenosis (i.e., narrowing or closure) of the treated area.
- For a general review of vascular stents, reference is made to “Textbook of Interventional Cardiology” edited by Eric J Topol, W. B. Saunders Company, 1994 and, in particular, to section IV of volume II, entitled “Coronary Stenting”.
- Many patents also provide a general review of stents, for example, U.S. Pat. Nos. 4,503,569; 4,768,507; 4,776,337; 4,800,882; 4,830,003; 4,856,516; 4,886,062; 4,907,336; and EP 0 201 466A.
- Notwithstanding the extensive research and experimentation in the stent field, as documented in the patent literature, only a relatively small number of operative solutions have, until now, found practical application. This is due to various factors, which include the following problems or requirements:
- while moving toward the treatment site, the stent should be capable of adapting to the path, which may include various curved sections;
- distortion of the stent while it is being positioned should not be detrimental to the ability of the stent to provide an effective support when it is positioned and deployed;
- the longitudinal shortening effect which occurs in many stents upon deployment should be limited, if not avoided;
- maximum homogeneity and uniformity in the expansion of the stent should be achieved at the desired location;
- an extensive support surface should be provided to the wall of the lumen which is being supported;
- the origination of complex shapes and/or possible stagnation sites, especially in blood vessels, should be avoided, in order to avoid undesirable phenomena such as coagulation or thrombosis; and
- the stents should be able to be simply and reliably produced using available technology and they should incorporate the requirements listed above.
- A stent is subject to various forces, including compression, flexure, and torsion. These stresses often cause the stent to perform in an undesirable manner. Additionally, a significant disadvantage of current stent designs is their failure to distribute these stresses throughout the structure of the stent. Each of these stresses is maximized in a particular area of the stent. In current stent designs two or more of these areas of maximum stress overlap. This results in at least two problems. First, an overlap of the maximum stress areas may overly fatigue the stent and cause failure in an area of overlapped maximum stress. Second, the failure to distribute or discharge the maximum stress of these forces at different areas causes stress concentration on the vessel wall which may cause vessel wall injury. Thus what is needed in the art is a stent meeting the requirements listed above that will avoid stress concentration and elastic distortion as well as provide good elastic matching between the stent and the vessel into which it is placed.
- This invention is a stent having a substantially tubular body defining a longitudinal axis comprising first and second adjacent annular segments, each segment defining a substantially sinusoidal shape having a plurality of peaks and valleys, the peaks of the first segment extending toward the second segment and being aligned longitudinally with the valleys of the second segment; a plurality of bridge elements having a U-shaped portion between first and second connector arms, the first connector arm of one bridge element being connected between a first peak and a first valley of the first segment and the second connector arm being connected between a first peak and a first valley of the second segment in a manner such that the U-shaped portion extends in the direction of the first peak of the first segment and the first valley of the second segment.
- The U-shaped portion of the plurality of bridge elements may be oriented in the same direction. Alternately, they may be oriented in one direction between one pair of adjacent annular segments, and in the opposite direction between another pair of adjacent annular segments. Preferably, the connector arm of the bridge element joins the annular segment at the zero point of the sinusoidal wave shape. In one embodiment, each connector arm joins each annular segment at zero points of the sinusoidal wave separated by 360°. Alternately, the connector arms may join zero points separated by 360° between one pair of adjacent segments, and zero points separated by 720° between another pair of adjacent segments.
- In a second aspect, this invention is a method of preventing restenosis by providing the stent described above and deploying it within a body lumen.
- In a third aspect, this invention is a method of making a stent by providing a tubular blank and forming the tubular blank into a stent having the geometry described above.
- In a further aspect this invention is a stent having a substantially tubular body defining a longitudinal axis. The stent comprises first and second adjacent annular segments, each segment having a substantially sinusoidal wave shape. The stent further includes first and second bridge elements, the first bridge element having a first end connected to the first annular segment at a zero point of the sinusoidal wave shape and having a second end connected to the second annular segment at a zero point of the sinusoidal wave shape. The second bridge element has a first end connected to the first annular segment at a zero point of the sinusoidal wave shape spaced 360° from the connection of the first bridge element to the first annular segment and a second end connected to the second annular segment at a zero point of the sinusoidal wave shape 360° from the connection of the first bridge element to the second segment, the first and second bridge elements and a portion of the first and second annular segments between the connection points of the bridge elements together defining a cell.
- In a further aspect, the invention is a stent having a substantially tubular body defining a longitudinal axis and having a plurality of annular segments, each segment having a substantially sinusoidal wave shape. The stent includes a plurality of bridge elements, each bridge element having a first end connected to one annular segment at a zero point of the sinusoidal wave shape and a second end connected to an annular segment adjacent to the one annular segment at a zero point of the sinusoidal wave shape of the adjacent annular segment, the annular segments and bridge elements being configured such that when compression, flexure and torsion forces are applied to the stent they generate first maximum stress regions, second maximum stress regions, and third maximum stress regions, where the first, second and third maximum stress regions do not overlap.
- The invention will now be described with reference to the accompanying drawings.
- FIG. 1 is a plan view of the tubular stent of the present invention cut longitudinally and opened to lie within a single plane, the stent being in a radially contracted configuration.
- FIG. 2 illustrates the stent of FIG. 1 in its radially expanded configuration.
- FIG. 3(a) illustrates an expanded view of a single cell within the wall of the stent of FIG. 2 and FIGS. 3(b), 3(c), 3(d), 3(c) and 3(f) show the cross-sectional areas of portions of the stent.
- FIGS.4(a) to 4(f) illustrate the effects of compression, flexure, and torsion, respectively, on a cell of the stent of this invention.
- FIGS.5(a) to 5(f) illustrate various shapes of the wall of a continuous tubular blank used to make the stent of this invention.
- FIGS.6(a) and 6(b) illustrate the variation in cross section of a section of the stent of this invention.
- FIG. 7 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
- FIG. 8 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
- FIG. 9 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
- FIG. 10 is a view similar to FIG. 1 of another embodiment of the stent of this invention.
- A stent is inserted into a lumen, such as a blood vessel, at a site where stenosis, i.e., narrowing or stricture, is to be corrected. The stent is a tubular envelope, tubular body, or cylinder having apertured walls, such as, for example, a mesh-like structure. The stent typically has dimensions between several millimeters and several tens of millimeters in length, and a wall thickness of the order of, for example, several hundredths of millimeters. The stent is normally positioned in situ by catheterization through the vasculature followed by radial expansion from an introduction diameter of, for example, about 1.0 to 1.5 mm, to an expanded diameter of, for example, about 3 to 4 mm. In this expanded condition, the stent exerts a supporting force on the lumen, thereby avoiding or at least slowing restenosis of the vessel. In general, the external diameter of the stent in the radially-contracted condition is chosen to enable the introduction of the stent into a lumen, while the expanded diameter corresponds to the diameter required to be maintained in the lumen once the stenosis has been eliminated. It should also be remembered that, although the principle application of the stent described is in relation to the treatment of blood vessels, it may also be useful as a support element for any lumen present in the human or animal body.
- The stent of this invention is a tubular body, i.e., a cylinder, with an open, or apertured, mesh-like structure. The stent is capable of being dilated from a radially-contracted position to a radially-expanded position. The tubular body is comprised of a wall having an inner surface and an outer surface defining a radial stent thickness therebetween. In one embodiment, the material making up the mesh-like structure of the stent varies in its cross-sectional shape and/or cross-sectional area. It has been discovered that this cross-sectional variation (and thus a variation in thickness and/or width in the stent wall) produces a particularly desirable stent because the strength, flexibility, and support of the stent may be varied in localized areas. In areas requiring flexibility, the width as measured along the circumference of the tubular body and/or the radial thickness are made smaller to enhance flexibility. In areas requiring strength, the width and/or thickness are made larger. In areas not requiring flexibility, the width is increased to provide added vascular support.
- In the embodiments illustrated in the Figures, the stent is shown in planar views so that the geometry of the stent may be seen easily. The body of the stent extends longitudinally in the direction identified as the Z axis. It also lies in the Z plane, i.e., a plane coincident with the Z axis. During delivery and use of the stent, the stent may be flexed, bent or folded; thus good flexibility is one of the required characteristics of the stent. Another important characteristic of both the design and the material of the stent includes strength, i.e., the ability to withstand stresses due to compression, flexure, and torsion, as discussed further below.
- FIG. 1 illustrates a plan view of the stent of this invention. The body of stent1 is comprised of a plurality of
successive segments 2 of generally annular form. FIG. 1 shows a stent comprising eightannular segments 2. Typically, the length ofsegments 2 measured in the longitudinal direction (i.e., along the Z axis) may range up to several millimeters (mm) but preferably is approximately 2 mm. That is,segments 2 are fairly “short” in comparison to the total length of the stent. - The various segments of stent1 are joined together by bridge elements 8 (which are actually integral components of the stent wall) that connect
adjacent segments 2 and enable stent 1 to flex or bend. -
Radiopaque marker 13 optionally is provided.Marker 13 is integral withsegments 2 and typically is located on the proximal and/or distal ends of the stent. “Proximal and distal ends” refers to the portion of the stent nearest and farthest, respectively, from the point of entry of the stent into the vasculature. Suitable radiopaque markers include metals such as platinum, tantalum, gold, and alloys of these metals. Such markers permit exact placement of a stent within the vasculature of a patient. During manufacture the radiopaque marker may be crimped into a hole in the stent wall. - The longitudinal flexibility of stent1, necessary to assist in its delivery and location at the implantation site, is essentially due to
bridge elements 8, while its structural strength, that is, its support of the lumen, is due primarily to the structure ofsegments 2. The desired characteristics of the stent can be obtained by adapting the arrangement and relationship of the bridge elements and the segments. - FIG. 1 shows a plan view of a stent which has been cut open and laid flat; that is, the stent is no longer in a tubular shape. FIG. 1 illustrates that each
segment 2 has a serpentine or sinusoidal wave shape. Each segment comprises peaks 4 and valleys 6. Each annular segment is a mirror image of an adjacent annular segment about a plane perpendicular to the longitudinal axis of the stent. Thus, the peaks of one segment are aligned longitudinally with valleys of an adjacent segment. For purposes of this description the term “sinusoidal wave shape” means that the annular segments have an undulating repeating pattern similar to that of a sine wave. It is not intended to mean that the shape is limited to that of a sine wave. -
Bridge elements 8 separate adjacent segments and maintain a distance between them in both the expanded and contracted conditions. Eachbridge element 8 comprises a concave portion, or U-shape 10, havingapex 12. The U-shape is adjoined to twoconnector arms 14 which extend from the U-shape and adjoin adjacent sinusoidal-shapedsegments 2 at a zero point of the sinusoidal wave shape of each segment. The point of connection is between a peak and a valley of each segment such that the apex of the U-shape extends in the direction of the converging peak and valley that is nearest the attachment of the connector arm. These arms extend away from the U-shape and curve back to join the segments in the direction of the apex of the U-shape. Preferably these arms form an angle α of about 90 degrees with the U-shape.Bridge elements 8 are relatively flexible and change shape only slightly from the contracted to the expanded condition, as can be seen in FIGS. 1 and 2.Arms 14 adjoin adjacent sinusoidal wave shaped segments between a peak and a valley and preferably at zero-point 11 of the sinusoidal shape. (On a sine curve plotted on an X and Y axis, the “zero-point” is that point that intersects the X axis.) - FIGS. 1 and 2 illustrate an embodiment of the stent of this invention wherein the connector arms of each bridge element adjoin alternate zero points of each adjacent segment. That is, in terms of the sinusoidal wave shape of each segment, bridge elements are connected at zero points separated by 360°. This results in even spacing of bridge elements between adjacent segments. In addition, the bridge elements are oriented in the same direction; that is, the U-shaped portion of each bridge element faces the same direction. It has been found that connection of the bridge elements at the zero points not only produces a very elastic joint but also results in the longitudinal length of the stent being the same in the contracted condition and the expanded condition and in all degrees of expansion therebetween.
- A radially-contracted condition of the stent is illustrated in FIG. 1. This condition is slightly expanded from the stents fully contracted delivery condition so that the details of the stents structure may be more clearly shown. The radially-expanded condition of the stent shown in FIG. 2. FIG. 2 shows that a
segment 2 is elongated compared to the same segment in FIG. 1. That is, the segments retain the sinusoidal shape, but the amplitude and the frequency of the sine wave is less in the expanded condition than in the contracted condition. FIGS. 1 and 2 also show that theconnector arms 14 remain substantially parallel to the longitudinal axis of the stent in both the radially contracted position (FIG. 1) and radially expanded position (FIG. 2). - An alternative way of describing the structure of the stents of this invention is in terms of its substantially tubular surface which includes multiple cells. FIG. 3(a), is a view of one cell of the stent of FIG. 2. FIGS. 1 and 2 illustrate that the stent is made up of individual, interconnected cells, each cell having the same size and shape. FIGS. 3(b) to 3(f) illustrate that the cross sectional shape and area of the material making up the stent varies over the cell. The perimeter of a cell is formed from portions of adjacent sinusoidal segments (2 a and 2 b) and two bridge elements (8 a and 8 b).
Sinusoidal segment portions 2 a and 2 b are 360° portions of the sinusoidal wave shape of the annular segments. Arms 14 a and 14 a′ extend from U-shape portion 10 a of bridge element 8 a. Apex 12 a of bridge 8 a is oriented in the same direction as apex 12 b of bridge 8 b. Bridges 8 a and 8 b adjoinadjacent segments 2 a and 2 b at zero points 11 of the sinusoidal shape; that is, between the peaks and valleys of the segments. Bridge element 8 b, having U-shape 10 b, apex 12 b, andarms - FIGS.3(b), 3(c), 3(d), 3(e) and 3(f) show the shape and size of the cross-section of different portions of the cell taken along lines b-b, c-c, d-d, e-e and f-f respectively. It is preferred that the cross-sectional area of the material making up the stent vary. The cross-sectional shape may vary as well. An alternate way of describing this is that the width of the material making up the stent of FIGS. 1 and 2 (i.e., the width of any portion of a bridge or a sinusoidal segment in plane Z) may be different than the thickness of that portion (i.e., the dimension in a plane X, perpendicular to plane Z). It has been found that varying the cross-sectional area of different portions of the material of the stent produces optimum strength, flexibility, and support, enabling the stent to accommodate the differing stresses it encounters during use.
- Through the use of stress analysis of the stent, it has been determined that during use, different areas of the cells are stressed, depending upon the forces acting on the stent. For example, when the stent is under compression, stress is maximized in the peaks and valleys of the sinusoidal segments. When the stent is flexed, the stress is maximized around the apex of the U-shape of the bridge elements. Under torsion, the stress is maximized at the ends of the connector arms of the bridge elements, i.e., where a bridge element connects to a sinusoidal segment.
- FIGS.4(a) to 4(f) illustrate the effects of compression, flexure, and torsion, respectively, on one cell of the stent of this invention. The arrows indicate the direction of the forces applied to the stent. The areas of the stent cell having the greatest stress concentration are indicated by solid lines. In FIG. 4(a), the stent is subjected to a compression force. FIG. 4(b) shows that the areas of greatest stress occurs at the peaks and valleys of the sinusoidal shaped segments. FIG. 4(c) shows s stent undergoing flexure. FIG. 4(d) indicates that the areas of greatest stress occur at the apex of the U-shape of the bridge. FIG. 4(e) shows a stent under torsion. FIG. 4(f) indicates that the maximum stress occurs at the areas where the bridge joins the sinusoidal shaped segments, i.e., at the zero point.
- It is an advantage of the cellular design of the stent of this invention that the areas of maximum stress induced by compression, flexure and torsion forces do not overlap. This reduces the risk that a particular area of the stent cell structure will be overly fatigued and fail. It also reduces the risk of causing damage to the vessel wall which can result if there is a significant stress concentration at any portion of the cellular structure. In the stent of this invention maximum stresses from compression, flexure and torsion are distributed and discharged over three separate areas of the cellular structure thus reducing the risk of stent failure and damage to vessel walls.
- In the stents of this invention, it is possible to alter the thickness and width of various portions of the stent during the manufacturing process. One way to do this is to form the desired wall geometry in a continuous tubular blank and then cut or machine the stent from this blank. For example, techniques such as laser incision, photo-incision, and electroerosion may be used to form a desired geometry. In this way, the stent bridges and sinusoidal segments are formed.
- FIG. 5a shows a continuous tubular blank from which stents can be formed. The tubular blank has
outer surface 51 forming the outer diameter andinner surface 53 forming the inner diameter; surfaces 51 and 53 are separated bywall thickness 55. The characteristics of the stent including wall thickness and shape can be varied in accordance with the shape and surface configuration of inner andouter surfaces - FIGS.6(a) and 6(b) show a further embodiment of the invention and illustrate how the shape of the wall of a continuous tubular blank corresponds to the stent of this invention. FIG. 6(a) shows a longitudinal cross-section of a portion of a tubular blank having a constant inner diameter but varying outer diameter. This blank is then used to form the sinusoidal segments and bridges of the stent. FIG. 6(b) shows that the regions of the bridges adjoining the sinusoidal shaped segments (i.e., at the zero point) may be made with a smaller thickness than the remaining portions of the stent.
- Turning now to FIG. 7, various alternative embodiments of the stent of this invention are illustrated. This stent comprises
bridge elements 78 adjoining sinusoidal shapedsegments 72 at zero points 71 of the sinusoidal shape. The bridge elements are evenly spaced. In this case the bridge elements are spaced apart 720° along the sinusoidal shape of the segments. The apices of each bridge element face the same direction. As described above, when viewed as a cellular structure, the stent of FIG. 4 illustrates cells all having the same shape and size. In contrast to FIGS. 1 and 2, this stent has fewer connecting bridges and fewer cells. - The stent of FIG. 8 is a hybrid of FIGS. 1 and 6.
Bridge elements 88 adjoinadjacent segments 82 at zeropoints 81 of the sinusoidal shape. All bridge elements are oriented similarly (i.e., face the same direction). The bridge elements adjoining adjacent segments are evenly spaced. However, the number and spacing of bridge elements is not the same for each pair of adjacent segments. This results in cells of unequal size and may produce regions of variable flexibility as well as strength. An advantage to having a greater number of bridge elements (and hence cells) at either end of the stent is that they provide additional stability and strength to the ends of the stent while having fewer cells in the middle portion of the stent provides additional flexibility. - Another variation of the stent is illustrated in FIG. 9. The bridge elements are evenly spaced throughout the stent, forming cells all of equal size and shape. However, apices (for example,90 a and 90 b) of bridge elements 98 face opposite directions in adjacent pairs of
segments 92. - FIG. 10 illustrates yet another variation of the stent, wherein U-shaped portions100 a and 100 b of
bridge elements 108 a and 108 b, respectively, are facing in opposite directions in adjacent pairs ofsegments 102 and wherein the cells formed at each end of the stent are of different size than those of the remaining cells. The bridge elements adjoining any pair of adjacent segments are evenly spaced, but the number and spacing of bridge elements is not the same for each pair of adjacent segments. This results in cells of unequal size, and, in similar fashion to FIG. 8, produces regions of greater strength at either end of the stent. - It is generally preferable to align the bridge elements between adjacent sinusoidal segments with the apices pointing in the direction of a converging peak and valley of the adjacent segments. This configuration provides a number of advantages. One advantage is that, in the expanded configuration, the stent cell structure is sufficiently open to permit access to the lumen. For example, it is possible to manipulate catheters through the stent wall into vessel bifurcations in order to treat those vessels. Another advantage is that the stent geometry provides a smooth profile for delivery when in the contracted position. In the stent design of this invention, the U-shape of the connecting bridges lies between a converging valley and peak of adjacent sinusoidal segments and acts as a bridge therebetween. This reduces the chance of snagging any cellular matter from the inside of the lumen. The peaks or valleys of some prior art stents protrude especially when the stent is bent during delivery. This protruding peak or valley can snag on a vessel wall or plaque, making delivery and positioning of the stent difficult. A further advantage is provided by the configuration of the bridge elements. The connector arms and U-shaped portion of the bridge elements act in cooperation with the segments to provide an effective support surface for the vessel wall while at the same time minimizing the amount of stent material which must be used.
- As to deployment (that is, the in situ expansion) of the stent, currently the most widely used method is to use a balloon catheter, disposing the stent about the balloon of the catheter in the contracted condition and then expanding the balloon once the stent has been delivered to the deployment site. Different solutions are also possible, such as using superelastic materials that expand when the stent reaches the implantation site. Typically these materials are held in a contracted condition by means of a containment element that is released when the stent has reached the desired location and position. Materials having a “shape memory” that expand from a first configuration to a second expanded configuration when heated to a transition temperature (i.e., body temperature) also may be used in order to achieve the radial expansion in the implant position.
- Usually the stent is made from a metal capable of satisfying two fundamental requirements: the ability to deform during the expansion phase and the ability to resist forces which could lead to contraction of the stent. That is, the stent retains the expanded shape. For example, the stents of this invention may comprise 316 stainless steel or a shape memory material known under the commercial designation “Nitinol”. “Nitinol” is a nickel-titanium alloy that has been shown to be successful due to its superelasticity as well as its shape memory. Stents also may comprise biodegradable and/or biocompatible polymers, as known to one of skill in the art.
- These technological aspects will not be dealt with in detail in the present description in that they are not in themselves relevant to the comprehension and production of the invention. This also applies essentially to the technology for the production of the stent according to the invention. As described above, the stent of this invention comprises a tubular body with an apertured wall. Methods of making the stent include:
- forming the stent from a continuous tubular blank intended to be segmented into individual stents, with the apertured parts being formed using techniques such as laser incision, photo-incision, electroerosion, and the like;
- forming the stent from a strip-like body in which the apertured zones are formed, for example, using the techniques listed above, with the subsequent closure of the strip-like element into a tube; and
- forming the stent from metal wire shaped by the subsequent attachment of wire loops, for example, using operations of micro welding, brazing, gluing, crimping, and the like.
- The first arrangement described is the one currently preferred for producing stents of this invention. In particular, the use of laser beams to cut a continuous tubular blank has been shown to be the most flexible way to modify rapidly the characteristics of the stent during production.
- Such methods may be used to produce a stent having either constant or variable wall thickness, and, in either case, with wall material having different cross-sections. These methods include making the stent from a continuous tubular blank and machining, grinding, chemically etching, or electron discharge machining the tube to produce the desired pattern and also obtain sections of desired cross-section. Alternatively, a tubular blank having constant or variable thickness down its length could be laser cut to form the desired arrangement of segments and bridges. A stent could be formed and then the inside surface could be turned or micro-etched.
- The production method is not critical to the stents of this invention, as they may be formed by any desired method. This applies to the choice of the individual techniques and the order in which the various operations (the production of the apertured parts, segmentation, possible folding of the strip-like element, etc.) are performed.
- Although particular embodiments have been disclosed herein in detail, this has been done for purposes of illustration only, and is not intended to be limiting with respect to the scope of the appended claims, which follow. In particular, it is contemplated by the inventor that various substitutions, alterations, and modifications may be made to the invention without departing from the spirit and scope of the invention as defined by the claims. For example, the frequency, number, and location of bridge elements and sinusoidal segments may be varied as necessary to obtain the desired characteristics of the stent.
Claims (12)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/410,303 US6451049B2 (en) | 1998-04-29 | 1999-10-01 | Stents for angioplasty |
ES00120834T ES2274758T3 (en) | 1999-10-01 | 2000-09-25 | STENTS FOR ANGIOPLASTIA. |
EP00120834A EP1088528B1 (en) | 1999-10-01 | 2000-09-25 | Stents for angioplasty |
DK00120834T DK1088528T3 (en) | 1999-10-01 | 2000-09-25 | Stents for angioplasty |
AT00120834T ATE343355T1 (en) | 1999-10-01 | 2000-09-25 | STENTS FOR ANGIOPLASTY |
DE60031490T DE60031490T2 (en) | 1999-10-01 | 2000-09-25 | Stents for angioplasty |
US10/159,969 US7273494B2 (en) | 1997-04-29 | 2002-05-31 | Stents for angioplasty |
US11/860,805 US20080288048A1 (en) | 1997-04-29 | 2007-09-25 | Stents for angioplasty |
US12/793,341 US20100241216A1 (en) | 1997-04-29 | 2010-06-03 | Stents for angioplasty |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/069,425 US6325821B1 (en) | 1997-04-29 | 1998-04-29 | Stent for angioplasty |
US09/410,303 US6451049B2 (en) | 1998-04-29 | 1999-10-01 | Stents for angioplasty |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/069,425 Continuation-In-Part US6325821B1 (en) | 1997-04-29 | 1998-04-29 | Stent for angioplasty |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/159,969 Continuation US7273494B2 (en) | 1997-04-29 | 2002-05-31 | Stents for angioplasty |
Publications (2)
Publication Number | Publication Date |
---|---|
US20010044649A1 true US20010044649A1 (en) | 2001-11-22 |
US6451049B2 US6451049B2 (en) | 2002-09-17 |
Family
ID=23624143
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/410,303 Expired - Lifetime US6451049B2 (en) | 1997-04-29 | 1999-10-01 | Stents for angioplasty |
US10/159,969 Expired - Lifetime US7273494B2 (en) | 1997-04-29 | 2002-05-31 | Stents for angioplasty |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/159,969 Expired - Lifetime US7273494B2 (en) | 1997-04-29 | 2002-05-31 | Stents for angioplasty |
Country Status (6)
Country | Link |
---|---|
US (2) | US6451049B2 (en) |
EP (1) | EP1088528B1 (en) |
AT (1) | ATE343355T1 (en) |
DE (1) | DE60031490T2 (en) |
DK (1) | DK1088528T3 (en) |
ES (1) | ES2274758T3 (en) |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010044650A1 (en) * | 2001-01-12 | 2001-11-22 | Simso Eric J. | Stent for in-stent restenosis |
US20020095207A1 (en) * | 2001-01-15 | 2002-07-18 | Yousuke Moriuchi | Stent |
US6589275B1 (en) * | 1998-02-25 | 2003-07-08 | William Cook Eurpoe Aps | Stent device |
US6846323B2 (en) | 2003-05-15 | 2005-01-25 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US20050033415A1 (en) * | 2001-06-13 | 2005-02-10 | Pelton Brian Lee | Double-butted superelastic nitinol tubing |
US20060155365A1 (en) * | 1996-09-19 | 2006-07-13 | Jacob Richter | Stent with variable features to optimize support and method of making such stent |
US20060173531A1 (en) * | 1996-09-19 | 2006-08-03 | Jacob Richter | Stent with variable features to optimize support and method of making such stent |
US20070088430A1 (en) * | 2003-03-19 | 2007-04-19 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal stent having mid-strut interconnecting members |
US7226475B2 (en) | 1999-11-09 | 2007-06-05 | Boston Scientific Scimed, Inc. | Stent with variable properties |
US7323189B2 (en) | 2001-10-22 | 2008-01-29 | Ev3 Peripheral, Inc. | Liquid and low melting coatings for stents |
US20080262601A1 (en) * | 2002-09-13 | 2008-10-23 | Cully Edward H | Stent Device with Multiple Helix Construction |
US20100228338A1 (en) * | 1998-03-27 | 2010-09-09 | Ev3 Inc. | Stents with tapered struts |
US7951188B2 (en) | 2000-05-03 | 2011-05-31 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US8043366B2 (en) | 2005-09-08 | 2011-10-25 | Boston Scientific Scimed, Inc. | Overlapping stent |
US8298244B2 (en) | 2006-10-26 | 2012-10-30 | Tyco Healtcare Group Lp | Intracorporeal grasping device |
US8632584B2 (en) | 2002-07-19 | 2014-01-21 | Dendron Gmbh | Medical implant having a curlable matrix structure and method of use |
US8679142B2 (en) | 2008-02-22 | 2014-03-25 | Covidien Lp | Methods and apparatus for flow restoration |
US20140114434A1 (en) * | 2012-10-22 | 2014-04-24 | Orbusneich Medical, Inc. | Medical device for implantation into luminal structures |
US20140277378A1 (en) * | 2013-03-15 | 2014-09-18 | Atrium Medical Corporation | Stent device having reduced foreshortening and recoil and method of making same |
US9039749B2 (en) | 2010-10-01 | 2015-05-26 | Covidien Lp | Methods and apparatuses for flow restoration and implanting members in the human body |
US20160220396A1 (en) * | 2011-09-09 | 2016-08-04 | Isis Innovation Limited | Stent and method of inserting a stent into a delivery catheter |
US20170100268A1 (en) * | 2014-03-25 | 2017-04-13 | World Medish Co., Ltd. | Flexible stent |
US9980835B2 (en) | 2013-10-22 | 2018-05-29 | Orbusneich Medical Inc. | Medical device for implantation into luminal structures incorporating corrugated structural elements |
WO2018143115A1 (en) * | 2017-02-01 | 2018-08-09 | 学校法人加計学園岡山理科大学 | Bioabsorbable stent |
US10076399B2 (en) | 2013-09-13 | 2018-09-18 | Covidien Lp | Endovascular device engagement |
US10413310B2 (en) | 2007-10-17 | 2019-09-17 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US10722255B2 (en) | 2008-12-23 | 2020-07-28 | Covidien Lp | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
CN111818882A (en) * | 2018-03-09 | 2020-10-23 | 维斯帕医疗公司 | Implantable stent |
US11020215B2 (en) * | 2012-06-15 | 2021-06-01 | Phraxis, Inc. | Venous anchor devices forming an anastomotic connector |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
CN117224297A (en) * | 2023-11-13 | 2023-12-15 | 太原理工大学 | Lower limb artery stent with reverse combined structure |
Families Citing this family (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US6235053B1 (en) | 1998-02-02 | 2001-05-22 | G. David Jang | Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors |
US20040106985A1 (en) | 1996-04-26 | 2004-06-03 | Jang G. David | Intravascular stent |
US6241760B1 (en) | 1996-04-26 | 2001-06-05 | G. David Jang | Intravascular stent |
JP4636634B2 (en) | 1996-04-26 | 2011-02-23 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Intravascular stent |
IT1289815B1 (en) * | 1996-12-30 | 1998-10-16 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT AND RELATED PRODUCTION PROCESS |
US6451049B2 (en) * | 1998-04-29 | 2002-09-17 | Sorin Biomedica Cardio, S.P.A. | Stents for angioplasty |
IT1292295B1 (en) * | 1997-04-29 | 1999-01-29 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT |
US6309414B1 (en) * | 1997-11-04 | 2001-10-30 | Sorin Biomedica Cardio S.P.A. | Angioplasty stents |
US6261319B1 (en) * | 1998-07-08 | 2001-07-17 | Scimed Life Systems, Inc. | Stent |
US7887578B2 (en) | 1998-09-05 | 2011-02-15 | Abbott Laboratories Vascular Enterprises Limited | Stent having an expandable web structure |
US6682554B2 (en) | 1998-09-05 | 2004-01-27 | Jomed Gmbh | Methods and apparatus for a stent having an expandable web structure |
US7815763B2 (en) * | 2001-09-28 | 2010-10-19 | Abbott Laboratories Vascular Enterprises Limited | Porous membranes for medical implants and methods of manufacture |
US6755856B2 (en) | 1998-09-05 | 2004-06-29 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
US6193744B1 (en) * | 1998-09-10 | 2001-02-27 | Scimed Life Systems, Inc. | Stent configurations |
US7758627B2 (en) * | 2000-03-01 | 2010-07-20 | Medinol, Ltd. | Longitudinally flexible stent |
US8920487B1 (en) | 2000-03-01 | 2014-12-30 | Medinol Ltd. | Longitudinally flexible stent |
EP1132058A1 (en) | 2000-03-06 | 2001-09-12 | Advanced Laser Applications Holding S.A. | Intravascular prothesis |
CN2430175Y (en) * | 2000-05-15 | 2001-05-16 | 臧式先 | Medical tubular rack |
JP4754714B2 (en) * | 2000-06-01 | 2011-08-24 | テルモ株式会社 | Intraluminal indwelling |
AU2001282959A1 (en) * | 2000-07-24 | 2002-02-05 | Jeffrey Grayzel | Stiffened balloon catheter for dilatation and stenting |
US20020072792A1 (en) | 2000-09-22 | 2002-06-13 | Robert Burgermeister | Stent with optimal strength and radiopacity characteristics |
US7766956B2 (en) | 2000-09-22 | 2010-08-03 | Boston Scientific Scimed, Inc. | Intravascular stent and assembly |
EP1364676A4 (en) * | 2001-02-01 | 2007-10-31 | Kaneka Corp | Stent |
US6942689B2 (en) * | 2001-03-01 | 2005-09-13 | Cordis Corporation | Flexible stent |
AU784552B2 (en) | 2001-03-02 | 2006-05-04 | Cardinal Health 529, Llc | Flexible stent |
DE10118944B4 (en) | 2001-04-18 | 2013-01-31 | Merit Medical Systems, Inc. | Removable, essentially cylindrical implants |
US6629994B2 (en) * | 2001-06-11 | 2003-10-07 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US6939373B2 (en) * | 2003-08-20 | 2005-09-06 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
DE60120955T3 (en) | 2001-07-20 | 2015-06-25 | Cid S.P.A. | stent |
US7547321B2 (en) | 2001-07-26 | 2009-06-16 | Alveolus Inc. | Removable stent and method of using the same |
EP1310242A1 (en) | 2001-11-13 | 2003-05-14 | SORIN BIOMEDICA CARDIO S.p.A. | Carrier and kit for endoluminal delivery of active principles |
US7147661B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
AU2002360765C1 (en) | 2001-12-20 | 2009-06-11 | Trivascular, Inc. | Advanced endovascular graft |
EP1348402A1 (en) * | 2002-03-29 | 2003-10-01 | Advanced Laser Applications Holding S.A. | Intraluminal endoprosthesis, radially expandable, perforated for drug delivery |
US6656220B1 (en) | 2002-06-17 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US6878162B2 (en) * | 2002-08-30 | 2005-04-12 | Edwards Lifesciences Ag | Helical stent having improved flexibility and expandability |
US9561123B2 (en) | 2002-08-30 | 2017-02-07 | C.R. Bard, Inc. | Highly flexible stent and method of manufacture |
US20040093056A1 (en) | 2002-10-26 | 2004-05-13 | Johnson Lianw M. | Medical appliance delivery apparatus and method of use |
US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
US7527644B2 (en) | 2002-11-05 | 2009-05-05 | Alveolus Inc. | Stent with geometry determinated functionality and method of making the same |
US7637942B2 (en) | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
US7959671B2 (en) | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
US20040102831A1 (en) * | 2002-11-22 | 2004-05-27 | Murray Robert J. | Stent having tapered edges |
US6923829B2 (en) | 2002-11-25 | 2005-08-02 | Advanced Bio Prosthetic Surfaces, Ltd. | Implantable expandable medical devices having regions of differential mechanical properties and methods of making same |
US20070239251A1 (en) * | 2002-12-31 | 2007-10-11 | Abbott Cardiovascular Systems Inc. | Flexible stent |
DE60334676D1 (en) | 2003-02-21 | 2010-12-09 | Sorin Biomedica Cardio Srl | Method for producing a stent and corresponding stent |
US7179286B2 (en) * | 2003-02-21 | 2007-02-20 | Boston Scientific Scimed, Inc. | Stent with stepped connectors |
US6862794B2 (en) * | 2003-03-03 | 2005-03-08 | Medtronic Ave, Inc. | Method for manufacturing an endovascular support device |
US7637934B2 (en) | 2003-03-31 | 2009-12-29 | Merit Medical Systems, Inc. | Medical appliance optical delivery and deployment apparatus and method |
US7604660B2 (en) | 2003-05-01 | 2009-10-20 | Merit Medical Systems, Inc. | Bifurcated medical appliance delivery apparatus and method |
US7789979B2 (en) * | 2003-05-02 | 2010-09-07 | Gore Enterprise Holdings, Inc. | Shape memory alloy articles with improved fatigue performance and methods therefor |
US20050060025A1 (en) * | 2003-09-12 | 2005-03-17 | Mackiewicz David A. | Radiopaque markers for medical devices |
US20050080479A1 (en) * | 2003-09-29 | 2005-04-14 | Feng James Q. | Expandable endovascular stent |
AU2004277962A1 (en) * | 2003-09-30 | 2005-04-14 | Alveolus Inc. | Removable stent |
DE10352874B4 (en) * | 2003-11-10 | 2008-03-27 | Qualimed Innovative Medizinprodukte Gmbh | stent |
ITTO20040056A1 (en) | 2004-02-05 | 2004-05-05 | Sorin Biomedica Cardio Spa | STENT FOR THE ENDOLIMINAL DELIVERY OF PRINCIPLES OR ACTIVE AGENTS |
US7479158B2 (en) * | 2004-02-20 | 2009-01-20 | Boston Scientific Scimed, Inc. | Stent with nested flexible connectors for flexibility and crimpability |
CA2557657C (en) | 2004-02-27 | 2013-06-18 | Aortx, Inc. | Prosthetic heart valve delivery systems and methods |
DE102004012981B4 (en) * | 2004-03-16 | 2009-01-02 | Alveolus Inc. | stent |
DE102004022044B4 (en) * | 2004-05-03 | 2008-12-18 | Qualimed Innovative Medizinprodukte Gmbh | stent |
WO2005104991A1 (en) * | 2004-05-05 | 2005-11-10 | Invatec S.R.L. | Endoluminal prosthesis |
US20050261757A1 (en) * | 2004-05-21 | 2005-11-24 | Conor Medsystems, Inc. | Stent with contoured bridging element |
US7780721B2 (en) | 2004-09-01 | 2010-08-24 | C. R. Bard, Inc. | Stent and method for manufacturing the stent |
DE102004045226B4 (en) * | 2004-09-17 | 2008-01-17 | Optiray Medizintechnik Gmbh | support prosthesis |
US7887579B2 (en) | 2004-09-29 | 2011-02-15 | Merit Medical Systems, Inc. | Active stent |
US7731654B2 (en) | 2005-05-13 | 2010-06-08 | Merit Medical Systems, Inc. | Delivery device with viewing window and associated method |
JP5141254B2 (en) * | 2005-10-06 | 2013-02-13 | 株式会社カネカ | Indwelling stent |
US20070191926A1 (en) * | 2006-02-14 | 2007-08-16 | Advanced Cardiovascular Systems, Inc. | Stent pattern for high stent retention |
CA3078016A1 (en) | 2006-02-14 | 2007-08-23 | Angiomed Gmbh & Co. Medizintechnik Kg | Highly flexible stent and method of manufacture |
US8403981B2 (en) | 2006-02-27 | 2013-03-26 | CardiacMC, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
US8147541B2 (en) | 2006-02-27 | 2012-04-03 | Aortx, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
AU2007249229B2 (en) * | 2006-05-12 | 2013-05-23 | Cardinal Health 529, Llc | Balloon expandable bioabsorbable drug eluting flexible stent |
GB0609841D0 (en) | 2006-05-17 | 2006-06-28 | Angiomed Ag | Bend-capable tubular prosthesis |
US8585594B2 (en) | 2006-05-24 | 2013-11-19 | Phoenix Biomedical, Inc. | Methods of assessing inner surfaces of body lumens or organs |
EP2034929A4 (en) | 2006-06-20 | 2010-04-07 | Aortx Inc | Prosthetic heart valves, support structures and systems and methods for implanting the same |
JP2009540952A (en) | 2006-06-20 | 2009-11-26 | エーオーテックス, インコーポレイテッド | Torque shaft and torque drive |
WO2007149933A2 (en) | 2006-06-21 | 2007-12-27 | Aortx, Inc. | Prosthetic valve implantation systems |
US7988720B2 (en) | 2006-09-12 | 2011-08-02 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US8778009B2 (en) * | 2006-10-06 | 2014-07-15 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
GB0622465D0 (en) | 2006-11-10 | 2006-12-20 | Angiomed Ag | Stent |
US9387100B2 (en) * | 2007-01-08 | 2016-07-12 | Cardinal Health Switzerland GmbH | Intraluminal medical device having variable axial flexibility about the circumference of the device |
US8333799B2 (en) * | 2007-02-12 | 2012-12-18 | C. R. Bard, Inc. | Highly flexible stent and method of manufacture |
US8328865B2 (en) | 2007-02-12 | 2012-12-11 | C. R. Bard, Inc. | Highly flexible stent and method of manufacture |
US8974514B2 (en) | 2007-03-13 | 2015-03-10 | Abbott Cardiovascular Systems Inc. | Intravascular stent with integrated link and ring strut |
WO2008124728A1 (en) * | 2007-04-09 | 2008-10-16 | Ev3 Peripheral, Inc. | Stretchable stent and delivery system |
US8128679B2 (en) | 2007-05-23 | 2012-03-06 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with torque-absorbing connectors |
US8016874B2 (en) * | 2007-05-23 | 2011-09-13 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with elevated scaffolding properties |
US7867273B2 (en) | 2007-06-27 | 2011-01-11 | Abbott Laboratories | Endoprostheses for peripheral arteries and other body vessels |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
WO2009046372A2 (en) | 2007-10-04 | 2009-04-09 | Trivascular2, Inc. | Modular vascular graft for low profile percutaneous delivery |
US9220522B2 (en) | 2007-10-17 | 2015-12-29 | Covidien Lp | Embolus removal systems with baskets |
US9198687B2 (en) | 2007-10-17 | 2015-12-01 | Covidien Lp | Acute stroke revascularization/recanalization systems processes and products thereby |
US8585713B2 (en) | 2007-10-17 | 2013-11-19 | Covidien Lp | Expandable tip assembly for thrombus management |
US8545514B2 (en) | 2008-04-11 | 2013-10-01 | Covidien Lp | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
US8926680B2 (en) * | 2007-11-12 | 2015-01-06 | Covidien Lp | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
US10123803B2 (en) | 2007-10-17 | 2018-11-13 | Covidien Lp | Methods of managing neurovascular obstructions |
US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
US8920488B2 (en) | 2007-12-20 | 2014-12-30 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having a stable architecture |
US7850726B2 (en) | 2007-12-20 | 2010-12-14 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having struts linked by foot extensions |
US8337544B2 (en) | 2007-12-20 | 2012-12-25 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having flexible connectors |
US8114149B2 (en) * | 2009-10-20 | 2012-02-14 | Svelte Medical Systems, Inc. | Hybrid stent with helical connectors |
US8434906B2 (en) * | 2010-02-23 | 2013-05-07 | General Electric Company | Lighting system with thermal management system |
DE102011057026B4 (en) * | 2011-12-23 | 2017-11-02 | Acandis Gmbh & Co. Kg | Medical device for insertion into a hollow body organ and manufacturing method |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
CN104490501A (en) * | 2014-12-25 | 2015-04-08 | 周玉杰 | Gradual changed thickness coronary stent suitable for coronary artery tortuosity angulation lesion |
JP6965336B2 (en) | 2016-03-31 | 2021-11-10 | ヴェスパー メディカル、 インコーポレイテッドVesper Medical, Inc. | Intravascular implant |
US10238513B2 (en) | 2017-07-19 | 2019-03-26 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US10849769B2 (en) | 2017-08-23 | 2020-12-01 | Vesper Medical, Inc. | Non-foreshortening stent |
US11628076B2 (en) | 2017-09-08 | 2023-04-18 | Vesper Medical, Inc. | Hybrid stent |
US11357650B2 (en) | 2019-02-28 | 2022-06-14 | Vesper Medical, Inc. | Hybrid stent |
US10271977B2 (en) | 2017-09-08 | 2019-04-30 | Vesper Medical, Inc. | Hybrid stent |
US11364134B2 (en) | 2018-02-15 | 2022-06-21 | Vesper Medical, Inc. | Tapering stent |
IT201900003579A1 (en) | 2019-03-12 | 2020-09-12 | Alvimedica Tibbi Ueruenler Sanayi Ve Dis Ticaret A S | STENT FOR CORONARY OSTIUM |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4503569A (en) | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
SE450809B (en) | 1985-04-10 | 1987-08-03 | Medinvent Sa | PLANT TOPIC PROVIDED FOR MANUFACTURING A SPIRAL SPRING SUITABLE FOR TRANSLUMINAL IMPLANTATION AND MANUFACTURED SPIRAL SPRINGS |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
EP0556940A1 (en) | 1986-02-24 | 1993-08-25 | Robert E. Fischell | Intravascular stent |
US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4907336A (en) | 1987-03-13 | 1990-03-13 | Cook Incorporated | Method of making an endovascular stent and delivery system |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US4830003A (en) | 1988-06-17 | 1989-05-16 | Wolff Rodney G | Compressive stent and delivery system |
US4856516A (en) | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
CA2380683C (en) | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
JP2703510B2 (en) | 1993-12-28 | 1998-01-26 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Expandable stent and method of manufacturing the same |
US5449373A (en) | 1994-03-17 | 1995-09-12 | Medinol Ltd. | Articulated stent |
US5733303A (en) | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
JP2825452B2 (en) | 1994-04-25 | 1998-11-18 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Radiopak stent marker |
JP3611578B2 (en) | 1994-11-09 | 2005-01-19 | エンドテックス インターベンショナル システムズ,インコーポレイテッド | Delivery catheter and graft for the treatment of aneurysms |
CA2301351C (en) | 1994-11-28 | 2002-01-22 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for direct laser cutting of metal stents |
US5591197A (en) | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
US5728131A (en) | 1995-06-12 | 1998-03-17 | Endotex Interventional Systems, Inc. | Coupling device and method of use |
US5776161A (en) | 1995-10-16 | 1998-07-07 | Instent, Inc. | Medical stents, apparatus and method for making same |
US5938682A (en) | 1996-01-26 | 1999-08-17 | Cordis Corporation | Axially flexible stent |
US5695516A (en) | 1996-02-21 | 1997-12-09 | Iso Stent, Inc. | Longitudinally elongating balloon expandable stent |
EP1066804B1 (en) | 1996-03-05 | 2004-07-14 | Evysio Medical Devices Ulc | Expandable stent |
US6334871B1 (en) | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
NZ331269A (en) | 1996-04-10 | 2000-01-28 | Advanced Cardiovascular System | Expandable stent, its structural strength varying along its length |
DE69727004T2 (en) | 1996-05-08 | 2004-11-25 | Sorin Biomedica Cardio S.P.A., Saluggia | A stent for angioplasty |
US5697971A (en) | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
IT1284708B1 (en) | 1996-07-26 | 1998-05-21 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT |
US5755781A (en) | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
US5776183A (en) | 1996-08-23 | 1998-07-07 | Kanesaka; Nozomu | Expandable stent |
US5807404A (en) * | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US5755776A (en) | 1996-10-04 | 1998-05-26 | Al-Saadon; Khalid | Permanent expandable intraluminal tubular stent |
DE19648012A1 (en) | 1996-11-20 | 1998-05-28 | Bayer Ag | Two-stage process for the production of semi-hard solid polyurethane moldings |
IT1289728B1 (en) | 1996-12-10 | 1998-10-16 | Sorin Biomedica Cardio Spa | SYSTEM AND EQUIPMENT DEVICE THAT INCLUDES IT |
FR2758253B1 (en) | 1997-01-10 | 1999-04-02 | Nycomed Lab Sa | IMPLANTABLE DEVICE FOR THE TREATMENT OF A BODY DUCT |
US5733330A (en) | 1997-01-13 | 1998-03-31 | Advanced Cardiovascular Systems, Inc. | Balloon-expandable, crush-resistant locking stent |
US5759174A (en) | 1997-01-29 | 1998-06-02 | Cathco, Inc. | Angioplasty balloon with an expandable external radiopaque marker band |
DE29701758U1 (en) | 1997-02-01 | 1997-03-27 | Jomed Implantate GmbH, 72414 Rangendingen | Radially expandable stent for implantation in a body vessel, particularly in the area of a vascular branch |
US5827321A (en) | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
DE29702671U1 (en) | 1997-02-17 | 1997-04-10 | Jomed Implantate GmbH, 72414 Rangendingen | Stent |
US5718713A (en) | 1997-04-10 | 1998-02-17 | Global Therapeutics, Inc. | Surgical stent having a streamlined contour |
DE19717476C2 (en) | 1997-04-25 | 1999-06-17 | Heraeus Gmbh W C | Radially expandable support structure |
US6033433A (en) * | 1997-04-25 | 2000-03-07 | Scimed Life Systems, Inc. | Stent configurations including spirals |
DE19717477C2 (en) | 1997-04-25 | 1999-12-09 | Heraeus Gmbh W C | Radially expandable support structure for keeping lumens open within a body |
IT1292295B1 (en) | 1997-04-29 | 1999-01-29 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT |
US6451049B2 (en) * | 1998-04-29 | 2002-09-17 | Sorin Biomedica Cardio, S.P.A. | Stents for angioplasty |
US5741327A (en) | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
US5913895A (en) | 1997-06-02 | 1999-06-22 | Isostent, Inc. | Intravascular stent with enhanced rigidity strut members |
FR2764794B1 (en) | 1997-06-20 | 1999-11-12 | Nycomed Lab Sa | EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS |
IT1293973B1 (en) | 1997-08-13 | 1999-03-15 | Sorin Biomedica Cardio Spa | ELEMENT FOR ANCHORING OF INSTALLATION DEVICES IN SITU. |
DE29716476U1 (en) | 1997-09-13 | 1997-12-18 | Convent, Gerd, 47829 Krefeld | Stenosis treatment stent |
EP1017336B1 (en) | 1997-09-24 | 2007-08-15 | Med Institute, Inc. | Radially expandable stent |
US6309414B1 (en) | 1997-11-04 | 2001-10-30 | Sorin Biomedica Cardio S.P.A. | Angioplasty stents |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6261319B1 (en) * | 1998-07-08 | 2001-07-17 | Scimed Life Systems, Inc. | Stent |
US6461380B1 (en) | 1998-07-28 | 2002-10-08 | Advanced Cardiovascular Systems, Inc. | Stent configuration |
CA2376069A1 (en) | 1999-06-30 | 2001-01-04 | Orlando M. Padilla | Variable thickness stent and method of manufacture thereof |
-
1999
- 1999-10-01 US US09/410,303 patent/US6451049B2/en not_active Expired - Lifetime
-
2000
- 2000-09-25 DK DK00120834T patent/DK1088528T3/en active
- 2000-09-25 EP EP00120834A patent/EP1088528B1/en not_active Expired - Lifetime
- 2000-09-25 ES ES00120834T patent/ES2274758T3/en not_active Expired - Lifetime
- 2000-09-25 DE DE60031490T patent/DE60031490T2/en not_active Expired - Lifetime
- 2000-09-25 AT AT00120834T patent/ATE343355T1/en not_active IP Right Cessation
-
2002
- 2002-05-31 US US10/159,969 patent/US7273494B2/en not_active Expired - Lifetime
Cited By (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090024206A1 (en) * | 1996-09-19 | 2009-01-22 | Jacob Richter | Stent with variable features to optimize support and method of making such stent |
US7998193B2 (en) | 1996-09-19 | 2011-08-16 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US7976576B2 (en) | 1996-09-19 | 2011-07-12 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US20060155365A1 (en) * | 1996-09-19 | 2006-07-13 | Jacob Richter | Stent with variable features to optimize support and method of making such stent |
US20060173531A1 (en) * | 1996-09-19 | 2006-08-03 | Jacob Richter | Stent with variable features to optimize support and method of making such stent |
US20100280593A1 (en) * | 1996-09-19 | 2010-11-04 | Medinol, Ltd. | Stent with variable features to optimize support and method of making such stent |
US7534257B2 (en) | 1996-09-19 | 2009-05-19 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US6589275B1 (en) * | 1998-02-25 | 2003-07-08 | William Cook Eurpoe Aps | Stent device |
US9034029B2 (en) * | 1998-03-27 | 2015-05-19 | Covidien Lp | Stents with tapered struts |
US20100228338A1 (en) * | 1998-03-27 | 2010-09-09 | Ev3 Inc. | Stents with tapered struts |
US7226475B2 (en) | 1999-11-09 | 2007-06-05 | Boston Scientific Scimed, Inc. | Stent with variable properties |
US7951188B2 (en) | 2000-05-03 | 2011-05-31 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US8449598B2 (en) | 2000-05-03 | 2013-05-28 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US20010044650A1 (en) * | 2001-01-12 | 2001-11-22 | Simso Eric J. | Stent for in-stent restenosis |
US7431732B2 (en) * | 2001-01-15 | 2008-10-07 | Terumo Kabushiki Kaisha | Stent with waved connecting members |
US20020095207A1 (en) * | 2001-01-15 | 2002-07-18 | Yousuke Moriuchi | Stent |
US20050033415A1 (en) * | 2001-06-13 | 2005-02-10 | Pelton Brian Lee | Double-butted superelastic nitinol tubing |
US8449905B2 (en) | 2001-10-22 | 2013-05-28 | Covidien Lp | Liquid and low melting coatings for stents |
US9333279B2 (en) | 2001-10-22 | 2016-05-10 | Covidien Lp | Coated stent comprising an HMG-CoA reductase inhibitor |
US7323189B2 (en) | 2001-10-22 | 2008-01-29 | Ev3 Peripheral, Inc. | Liquid and low melting coatings for stents |
US8900618B2 (en) | 2001-10-22 | 2014-12-02 | Covidien Lp | Liquid and low melting coatings for stents |
US8632584B2 (en) | 2002-07-19 | 2014-01-21 | Dendron Gmbh | Medical implant having a curlable matrix structure and method of use |
US11426293B2 (en) | 2002-07-19 | 2022-08-30 | Ussc Medical Gmbh | Medical implant |
US10342683B2 (en) | 2002-07-19 | 2019-07-09 | Ussc Medical Gmbh | Medical implant having a curlable matrix structure and method of use |
US20080262601A1 (en) * | 2002-09-13 | 2008-10-23 | Cully Edward H | Stent Device with Multiple Helix Construction |
US20070088430A1 (en) * | 2003-03-19 | 2007-04-19 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal stent having mid-strut interconnecting members |
US7980289B2 (en) * | 2003-03-19 | 2011-07-19 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal stent having mid-strut interconnecting members |
US6846323B2 (en) | 2003-05-15 | 2005-01-25 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US8043366B2 (en) | 2005-09-08 | 2011-10-25 | Boston Scientific Scimed, Inc. | Overlapping stent |
US8298244B2 (en) | 2006-10-26 | 2012-10-30 | Tyco Healtcare Group Lp | Intracorporeal grasping device |
US10413310B2 (en) | 2007-10-17 | 2019-09-17 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US8940003B2 (en) | 2008-02-22 | 2015-01-27 | Covidien Lp | Methods and apparatus for flow restoration |
US11529156B2 (en) | 2008-02-22 | 2022-12-20 | Covidien Lp | Methods and apparatus for flow restoration |
US8679142B2 (en) | 2008-02-22 | 2014-03-25 | Covidien Lp | Methods and apparatus for flow restoration |
US9161766B2 (en) | 2008-02-22 | 2015-10-20 | Covidien Lp | Methods and apparatus for flow restoration |
US10456151B2 (en) | 2008-02-22 | 2019-10-29 | Covidien Lp | Methods and apparatus for flow restoration |
US10722255B2 (en) | 2008-12-23 | 2020-07-28 | Covidien Lp | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US9039749B2 (en) | 2010-10-01 | 2015-05-26 | Covidien Lp | Methods and apparatuses for flow restoration and implanting members in the human body |
US10426644B2 (en) | 2010-10-01 | 2019-10-01 | Covidien Lp | Methods and apparatuses for flow restoration and implanting members in the human body |
US20160220396A1 (en) * | 2011-09-09 | 2016-08-04 | Isis Innovation Limited | Stent and method of inserting a stent into a delivery catheter |
US10383749B2 (en) * | 2011-09-09 | 2019-08-20 | Oxford University Innovation Limited | Stent and method of inserting a stent into a delivery catheter |
US11020215B2 (en) * | 2012-06-15 | 2021-06-01 | Phraxis, Inc. | Venous anchor devices forming an anastomotic connector |
CN104869945A (en) * | 2012-10-22 | 2015-08-26 | 奥巴斯尼茨医学公司 | Medical device for implantation into luminal structures |
US20140114434A1 (en) * | 2012-10-22 | 2014-04-24 | Orbusneich Medical, Inc. | Medical device for implantation into luminal structures |
US10271975B2 (en) * | 2013-03-15 | 2019-04-30 | Atrium Medical Corporation | Stent device having reduced foreshortening and recoil and method of making same |
US20140277378A1 (en) * | 2013-03-15 | 2014-09-18 | Atrium Medical Corporation | Stent device having reduced foreshortening and recoil and method of making same |
US10842656B2 (en) | 2013-03-15 | 2020-11-24 | Atrium Medical Corporation | Stent device having reduced foreshortening and recoil and method of making same |
US10076399B2 (en) | 2013-09-13 | 2018-09-18 | Covidien Lp | Endovascular device engagement |
US11304712B2 (en) | 2013-09-13 | 2022-04-19 | Covidien Lp | Endovascular device engagement |
US9980835B2 (en) | 2013-10-22 | 2018-05-29 | Orbusneich Medical Inc. | Medical device for implantation into luminal structures incorporating corrugated structural elements |
US10420660B2 (en) * | 2014-03-25 | 2019-09-24 | World Medish Technology Co., Ltd. | Flexible stent |
US20170100268A1 (en) * | 2014-03-25 | 2017-04-13 | World Medish Co., Ltd. | Flexible stent |
JPWO2018143115A1 (en) * | 2017-02-01 | 2019-11-07 | 学校法人加計学園 岡山理科大学 | Bioabsorbable stent |
AU2018214780B2 (en) * | 2017-02-01 | 2022-02-03 | Japan Medical Device Technology Co., Ltd. | Bioabsorbable stent |
US11135075B2 (en) | 2017-02-01 | 2021-10-05 | Kake Educational Institution Okayama University Of Science | Bioabsorbable stent |
WO2018143115A1 (en) * | 2017-02-01 | 2018-08-09 | 学校法人加計学園岡山理科大学 | Bioabsorbable stent |
JP2021517025A (en) * | 2018-03-09 | 2021-07-15 | ヴェスパー メディカル、 インコーポレイテッドVesper Medical, Inc. | Implantable stent |
CN111818882A (en) * | 2018-03-09 | 2020-10-23 | 维斯帕医疗公司 | Implantable stent |
JP7373495B2 (en) | 2018-03-09 | 2023-11-02 | ヴェスパー メディカル、 インコーポレイテッド | implantable stent |
US11980555B2 (en) | 2018-03-09 | 2024-05-14 | Vesper Medical, Inc. | Implantable stent |
CN117224297A (en) * | 2023-11-13 | 2023-12-15 | 太原理工大学 | Lower limb artery stent with reverse combined structure |
Also Published As
Publication number | Publication date |
---|---|
DE60031490T2 (en) | 2007-03-29 |
DK1088528T3 (en) | 2007-02-26 |
US6451049B2 (en) | 2002-09-17 |
ATE343355T1 (en) | 2006-11-15 |
EP1088528A1 (en) | 2001-04-04 |
DE60031490D1 (en) | 2006-12-07 |
EP1088528B1 (en) | 2006-10-25 |
ES2274758T3 (en) | 2007-06-01 |
US20020183831A1 (en) | 2002-12-05 |
US7273494B2 (en) | 2007-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6451049B2 (en) | Stents for angioplasty | |
US20080288048A1 (en) | Stents for angioplasty | |
US7625398B2 (en) | Endoprosthesis having foot extensions | |
US8048146B2 (en) | Endoprosthesis having foot extensions | |
US7985249B2 (en) | Endoprosthesis having foot extensions | |
EP1954223B1 (en) | Stent configurations | |
US7625401B2 (en) | Endoprosthesis having foot extensions | |
US7273492B2 (en) | Stent for treating vulnerable plaque | |
EP1477136B1 (en) | Longitudinally flexible expandable stent | |
JP3568899B2 (en) | Medical device for intraluminal intravascular stent | |
US8075610B2 (en) | Endoprosthesis for controlled contraction and expansion | |
US9427340B2 (en) | Stent with protruding branch portion for bifurcated vessels | |
US20120143315A1 (en) | Longitudinally flexible expandable stent | |
US20070073384A1 (en) | Longitudinally flexible expandable stent | |
US20070135891A1 (en) | Stent having an expandable web structure | |
US20110160840A1 (en) | Repetitive Cell Bifurcation / Side Branch Ostia Support Stent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SORIN BIOMEDICA CARDIO S.P.A., ITALY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VALLANA, FRANCO;ROLANDO, GIOVANNI;CURCIO, MARIA;AND OTHERS;REEL/FRAME:010571/0376 Effective date: 20000105 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: SORIN BIOMEDICA CARDIO S.R.L., ITALY Free format text: CHANGE OF NAME;ASSIGNOR:SORIN BIOMEDICA CARDIO S.P.A.;REEL/FRAME:021876/0393 Effective date: 20041006 |
|
AS | Assignment |
Owner name: INTERVASCULAR C.V., NETHERLANDS Free format text: EXCERPTED ASSET PURCHASE AGREEMENT;ASSIGNOR:SORIN BIOMEDICA CARDIO S.R.L.;REEL/FRAME:022191/0138 Effective date: 20080610 |
|
AS | Assignment |
Owner name: INTERVASCULAR C.V., NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SORIN BIOMEDICA CARDIO S.R.L.;REEL/FRAME:022203/0679 Effective date: 20080610 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
AS | Assignment |
Owner name: CID S.P.A., ITALY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTERVASCULAR C.V.;REEL/FRAME:029597/0790 Effective date: 20120917 |
|
FPAY | Fee payment |
Year of fee payment: 12 |